scispace - formally typeset
R

Roger Gundle

Researcher at Nuffield Orthopaedic Centre

Publications -  61
Citations -  5193

Roger Gundle is an academic researcher from Nuffield Orthopaedic Centre. The author has contributed to research in topics: Hip resurfacing & Oxford hip score. The author has an hindex of 27, co-authored 59 publications receiving 4668 citations. Previous affiliations of Roger Gundle include University of Oxford.

Papers
More filters
Journal ArticleDOI

Pseudotumours associated with metal-on-metal hip resurfacings

TL;DR: The most common symptom was discomfort in the region of the hip and other symptoms included spontaneous dislocation, nerve palsy, a noticeable mass or a rash as mentioned in this paper, and the common histological features were extensive necrosis and lymphocytic infiltration.

Pseudotumours associated with metal-on-metal hip resurfacings

TL;DR: It is estimated that approximately 1% of patients who have a metal-on-metal resurfacing develop a pseudotumour within five years, which is probably multifactorial and may be a toxic reaction to an excess of particulate metal wear debris or a hypersensitivity reaction to a normal amount of metal debris.
Journal ArticleDOI

Oral versus intravenous antibiotics for bone and joint infection

TL;DR: Oral antibiotic therapy was noninferior to intravenous antibiotic therapy when used during the first 6 weeks for complex orthopedic infection, as assessed by treatment failure at 1 year after randomization.
Journal ArticleDOI

Hip resurfacings revised for inflammatory pseudotumour have a poor outcome

TL;DR: The outcome of revision for pseudotumour in metal-on-metal hip resurfacing revisions is poor and consideration should be given to early revision to limit the extent of the soft-tissue destruction.
Journal ArticleDOI

One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome

TL;DR: Treatment failure rates by antibiotic duration for prosthetic joint infection managed with debridement, antibiotics and implant retention (DAIR) are described and PJI may be managed by DAIR.